Your browser doesn't support javascript.
loading
Corrigendum: Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma.
Chen, Yaxin; Xia, Lei; Peng, Yuxuan; Wang, Gang; Bi, Liyun; Xiao, Xue; Li, Cui; Li, Weimin.
Affiliation
  • Chen Y; Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Xia L; Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China.
  • Peng Y; Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Wang G; Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
  • Bi L; Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
  • Xiao X; Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Li C; Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
  • Li W; Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Front Oncol ; 13: 1309950, 2023.
Article in En | MEDLINE | ID: mdl-38023249
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2022.947808.].
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: China